224 related articles for article (PubMed ID: 22871659)
21. Recommendations for the collection and annotation of biosamples for analysis of biomarkers in neurofibromatosis and schwannomatosis clinical trials.
Sundby RT; Rhodes SD; Komlodi-Pasztor E; Sarnoff H; Grasso V; Upadhyaya M; Kim A; Evans DG; Blakeley JO; Hanemann CO; Bettegowda C
Clin Trials; 2024 Feb; 21(1):40-50. PubMed ID: 37904489
[TBL] [Abstract][Full Text] [Related]
22. [Neurofibromatosis with abdominal and severe central nervous system complications].
Nagy K; Podányi B; Eróss L; Bazsó P; Szabó Z; Bodrogi L
Orv Hetil; 1996 Nov; 137(44):2465-8. PubMed ID: 9026761
[TBL] [Abstract][Full Text] [Related]
23. Hybrid neurofibroma/schwannoma is overrepresented among schwannomatosis and neurofibromatosis patients.
Harder A; Wesemann M; Hagel C; Schittenhelm J; Fischer S; Tatagiba M; Nagel C; Jeibmann A; Bohring A; Mautner VF; Paulus W
Am J Surg Pathol; 2012 May; 36(5):702-9. PubMed ID: 22446939
[TBL] [Abstract][Full Text] [Related]
24. Genotype-Phenotype Correlations in Neurofibromatosis and Their Potential Clinical Use.
Bettegowda C; Upadhayaya M; Evans DG; Kim A; Mathios D; Hanemann CO;
Neurology; 2021 Aug; 97(7 Suppl 1):S91-S98. PubMed ID: 34230207
[TBL] [Abstract][Full Text] [Related]
25. [Disseminated cutaneous neurilemmomatosis].
Thomas L; Chaudier J; Fiere A; Choquet G; Balme B; Barrut D; Kanitakis J; Moulin G
Ann Dermatol Venereol; 1995; 122(8):509-11. PubMed ID: 8572488
[TBL] [Abstract][Full Text] [Related]
26. Eruptive plexiform schwannomas in a child with neurofibromatosis I.
Itenberg S; Turner R; Amin B; Jacobson M; Krishnamurthy K
J Drugs Dermatol; 2011 Oct; 10(10):1210-1. PubMed ID: 21968676
[No Abstract] [Full Text] [Related]
27. From process to progress-2017 International Conference on Neurofibromatosis 1, Neurofibromatosis 2 and Schwannomatosis.
Ferner RE; Bakker A; Elgersma Y; Evans DGR; Giovannini M; Legius E; Lloyd A; Messiaen LM; Plotkin S; Reilly KM; Schindeler A; Smith MJ; Ullrich NJ; Widemann B; Sherman LS
Am J Med Genet A; 2019 Jun; 179(6):1098-1106. PubMed ID: 30908866
[TBL] [Abstract][Full Text] [Related]
28. Cutaneous plexiform schwannoma of the finger not associated with neurofibromatosis.
Punia RS; Dhingra N; Mohan H
Am J Clin Dermatol; 2008; 9(2):129-31. PubMed ID: 18284268
[TBL] [Abstract][Full Text] [Related]
29. Multiple schwannomas in the peripheral nerves.
Ogose A; Hotta T; Morita T; Otsuka H; Hirata Y
J Bone Joint Surg Br; 1998 Jul; 80(4):657-61. PubMed ID: 9699832
[TBL] [Abstract][Full Text] [Related]
30. Von Recklinghausen's disease associated with multiple neurolemomas.
Izumi AK; Rosato FE; Wood MG
Arch Dermatol; 1971 Aug; 104(2):172-6. PubMed ID: 4999179
[No Abstract] [Full Text] [Related]
31. Neurofibromatosis of atypical presentation.
Tato BP; Sáez AC; Recuero JL; Dorado MM; Fernández PR; de Paz FS
J Eur Acad Dermatol Venereol; 2005 Sep; 19(5):608-11. PubMed ID: 16164720
[TBL] [Abstract][Full Text] [Related]
32. Case of schwannomatosis.
Murakami Y; Wataya-Kaneda M; Tanaka M; Myoui A; Sakata Y; Katayama I
J Dermatol; 2009 Sep; 36(9):508-11. PubMed ID: 19712279
[TBL] [Abstract][Full Text] [Related]
33. Schwannomatosis: a clinical entity distinct from neurofibromatosis type 2.
Wolkenstein P; Benchikhi H; Zeller J; Wechsler J; Revuz J
Dermatology; 1997; 195(3):228-31. PubMed ID: 9407167
[TBL] [Abstract][Full Text] [Related]
34. Current status and recommendations for biomarkers and biobanking in neurofibromatosis.
Hanemann CO; Blakeley JO; Nunes FP; Robertson K; Stemmer-Rachamimov A; Mautner V; Kurtz A; Ferguson M; Widemann BC; Evans DG; Ferner R; Carroll SL; Korf B; Wolkenstein P; Knight P; Plotkin SR;
Neurology; 2016 Aug; 87(7 Suppl 1):S40-8. PubMed ID: 27527649
[TBL] [Abstract][Full Text] [Related]
35. [Multiple peripheral nerve tumors: update and review of the literature].
Chick G; Alnot JY; Silbermann-Hoffman O
Chir Main; 2003 Jun; 22(3):131-7. PubMed ID: 12889267
[TBL] [Abstract][Full Text] [Related]
36. First use of patient reported outcomes measurement information system (PROMIS) measures in adults with neurofibromatosis.
Talaei-Khoei M; Riklin E; Merker VL; Sheridan MR; Jordan JT; Plotkin SR; Vranceanu AM
J Neurooncol; 2017 Jan; 131(2):413-419. PubMed ID: 27900643
[TBL] [Abstract][Full Text] [Related]
37. Relationship between whole-body tumor burden, clinical phenotype, and quality of life in patients with neurofibromatosis.
Merker VL; Bredella MA; Cai W; Kassarjian A; Harris GJ; Muzikansky A; Nguyen R; Mautner VF; Plotkin SR
Am J Med Genet A; 2014 Jun; 164A(6):1431-7. PubMed ID: 24664633
[TBL] [Abstract][Full Text] [Related]
38. Giant nevus lipomatosus cutaneous superficialis with intramuscular lipomatosis.
Jung ST; Park HW; Yun SJ
J Am Acad Dermatol; 2012 Oct; 67(4):e168-70. PubMed ID: 22980286
[No Abstract] [Full Text] [Related]
39. [Neurofibromatoses. Types, classification and diagnostic criteria].
Poptodorov G
Khirurgiia (Sofiia); 2001; 57(1-2):56-8. PubMed ID: 12024659
[TBL] [Abstract][Full Text] [Related]
40. Generalized cutaneous cylindromatosis.
Rubin MG; Mitchell AJ
Cutis; 1984 Jun; 33(6):568-9. PubMed ID: 6086239
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
